CytomX Therapeutics, Inc.

Q2 2024 13F Holders

Symbol
CTMX
CUSIP
23284F105
Type
Equity
Class
COM
Num filers
75
Total reported value, excl. options
$61.9M
Manager Report Date Value ($000) Shares